BioCryst Presents Data Showing Sustained Attack Rate Reductions, Improved Patient Satisfaction and Quality of Life for HAE Patients Taking Berotralstat in APeX-2 Trial

Ads

You May Also Like

Nabriva Therapeutics to Present Lefamulin Data at ASM Microbe

Potential of Lefamulin to Treat Patients with CABP Against Backdrop of Increasing Bacterial Resistance ...

The Board of Directors of Orion Corporation decided on an incentive plan for key persons

                                                                         ORION CORPORATION  STOCK EXCHANGE RELEASE    2 FEB 2016  AT 14:45 PM EET               ...